...

NIH Announces the Launch of the 2018-2019 Niche Assessment Program

E3cf4d1b781fd877fe88e4764683408b184108e1

NIH has announced the launch of the 2018-2019 Niche Assessment Program available to HHS (NIH, CDC, FDA) SBIR and STTR Phase I awardees and Phase I Fast-Track awardees (by grant or contract). Though the Niche Assessment program, Foresight Science & Technology provides an unbiased third-party assessment of appropriate market niches for products/services that are being developed by HHS SBIR/STTR Phase I awardees on behalf of NIH. Using its Technology Niche Analysis® (TNA®), Foresight will perform the due diligence on markets appropriate for each SBIR technology and develop an in-depth report for each SBIR/STTR awardee that addresses:

  • needs and concerns of end-users
  • competing technologies and competing products
  • competitive advantage of the SBIR/STTR-developed technology
  • market size and potential market share (may include national and/or global markets)
  • barriers to market entry (may include, but is not limited to pricing, competition, government regulations, manufacturing challenges, capital requirements, etc.)
  • market drivers
  • status of market and industry trends
  • potential customers, licensees, investors, or other commercialization partners
  • price customers are likely to pay

There are 200 slots for the Niche Assessment Program this year!

Learn more here: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-012.html

Share this article

Results That Speak for Themselves

Ready to understand your market—and make your move?

Let’s explore how your technology fits into the real world. Contact us to learn more about how a Foresight assessment can support your next funding round, licensing plan, or commercialization strategy.